{"id":628033,"date":"2024-05-05T18:50:28","date_gmt":"2024-05-05T22:50:28","guid":{"rendered":"https:\/\/www.singlecare.com\/blog\/?p=628033"},"modified":"2024-10-25T09:58:44","modified_gmt":"2024-10-25T13:58:44","slug":"biktarvy-alternatives","status":"publish","type":"post","link":"https:\/\/www.singlecare.com\/blog\/biktarvy-alternatives\/","title":{"rendered":"Biktarvy alternatives: What can I take instead of Biktarvy?"},"content":{"rendered":"

Biktarvy<\/span><\/a> is a brand-name prescription medication approved by the U.S. Food and Drug Administration (<\/span>FDA<\/span><\/a>) to treat human immunodeficiency virus type 1 (HIV-1) infections. Biktarvy is recommended as an initial treatment option for people starting HIV-1 therapy. HIV-1 infections weaken a person’s immune system by destroying important cells that fight disease and infection. Biktarvy is a tablet taken by mouth once daily. It contains three different medicines called antiretrovirals (ARV). This includes bictegravir, emtricitabine, and tenofovir alafenamide fumarate. As a combination tablet containing different classes of HIV medicines, Biktarvy is considered a complete regimen for treating <\/span>HIV-1 infections<\/span><\/a>. <\/span><\/p>\n

The treatment for HIV is called antiretroviral therapy (ART), and it helps reduce the amount of HIV in a person’s body. ART consists of taking a combination of HIV medicines, which is called an HIV treatment regimen. Typically, an initial HIV treatment regimen includes three HIV medicines from at least two different HIV drug classes. People must start HIV treatment as soon as possible after diagnosis as delaying treatment can put someone at a higher risk of transmitting an HIV infection to partners, getting sick, and developing AIDS (acquired immunodeficiency syndrome). <\/span><\/p>\n

Many HIV medications have significant drug interactions with other drugs, so it is important to review medication lists with a healthcare provider. Antiretroviral medications share <\/span>common side effects<\/span><\/a>, including nausea, vomiting, diarrhea, difficulty sleeping, headache, dizziness, dry mouth, rash, and fatigue. <\/span><\/p>\n

While there is currently no effective cure for HIV, this condition can be controlled with proper medical care. The Centers for Disease Control and Prevention (CDC) estimated that in 2021, <\/span>approximately 1.2 million people<\/span><\/a> in the United States had HIV. When it comes to Biktarvy tablets, despite being an effective treatment for some people, it may not be the best and safest treatment for everyone treating HIV-1 infections.<\/span><\/p>\n

What can I take in place of Biktarvy?<\/span><\/h2>\n

There are other FDA-approved options available to treat HIV-1 infections that do not improve with Biktarvy. These alternative prescription medications include other antiretroviral therapies, such as oral and injectable options. Most antiretroviral therapies involve two, three, or more medications across various drug classes. Certain HIV-1 treatments will work better for some people as the medications do not affect everyone in the same way, so a change in therapy is not unusual. Healthcare providers can consult an HIV specialist with additional questions or concerns about regimen switches. These options may be more suitable for certain individuals <\/span>due to their dosing schedule<\/span><\/a>, route of administration, side effect profiles, and cost.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Compare Biktarvy alternatives<\/span><\/h2>\n<\/th>\n<\/tr>\n<\/thead>\n

Drug name<\/b><\/td>\nUses<\/b><\/td>\nDosage<\/b><\/td>\nSavings options<\/b><\/td>\n<\/tr>\n
Biktarvy <\/span><\/p>\n

(bictegravir\/emtricitabine\/<\/span><\/p>\n

tenofovir alafenamide fumarate)<\/span><\/td>\n

Treatment of HIV-1 infection<\/span><\/td>\nTake 1 tablet by mouth once daily<\/span><\/td>\nBiktarvy coupons<\/span><\/a><\/td>\n<\/tr>\n
Cabenuva <\/span><\/p>\n

(cabotegravir\/ rilpivirine)<\/span><\/td>\n

Treatment of HIV-1 infection<\/span><\/td>\nInjected by a healthcare professional by gluteal intramuscular (into the muscle) administration once monthly<\/span><\/td>\nCabenuva coupons<\/span><\/a><\/td>\n<\/tr>\n
Dovato <\/span><\/p>\n

(dolutegravir\/lamivudine) <\/span><\/td>\n

Treatment of HIV-1 infection<\/span><\/td>\nTake 1 tablet by mouth once daily<\/span><\/td>\nDovato coupons<\/span><\/a><\/td>\n<\/tr>\n
Genvoya <\/span><\/p>\n

(elvitegravir\/cobicistat\/<\/span><\/p>\n

emtricitabine\/tenofovir alafenamide)<\/span><\/td>\n

Treatment of HIV-1 infection<\/span><\/td>\nTake 1 tablet by mouth once daily<\/span><\/td>\nGenvoya coupons<\/span><\/a><\/td>\n<\/tr>\n
Juluca <\/span><\/p>\n

(dolutegravir\/rilpivirine)<\/span><\/td>\n

Treatment of HIV-1 infection<\/span><\/td>\nTake 1 tablet by mouth once daily<\/span><\/td>\nJuluca coupons<\/span><\/a><\/td>\n<\/tr>\n
Stribild <\/span><\/p>\n

(elvitegravir\/cobicistat\/ emtricitabine\/tenofovir disoproxil fumarate)<\/span><\/td>\n

Treatment of HIV-1 infection<\/span><\/td>\nTake 1 tablet by mouth once daily<\/span><\/td>\nStribild coupons<\/span><\/a><\/td>\n<\/tr>\n
Triumeq <\/span><\/p>\n

(dolutegravir\/abacavir\/<\/span><\/p>\n

lamivudine)<\/span><\/td>\n

Treatment of HIV-1 infection<\/span><\/td>\nTake 1 tablet by mouth once daily<\/span><\/td>\nTriumeq coupons<\/span><\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Other alternatives to Biktarvy<\/span><\/h3>\n

Other HIV-1 infection therapy options include combining several drugs to make a complete regimen. While the above alternatives listed are combination medications that can be more convenient and do not require multiple tablets or capsules, healthcare providers can prescribe individual drugs to ensure a complete regimen. Some of the alternatives listed below can be considered as individual parts to make a complete treatment regimen:<\/span><\/p>\n

Combination Medications<\/span><\/p>\n